Editas Medicine terminates CMO Lisa Michaels effective immediately

Editas Medicine, Inc.

Lisa Michaels' employment as Chief Medical Officer terminated on February 7, 2022.
Severance includes base salary for 12 months, COBRA contributions, and unpaid prior bonus.
Payments contingent on signing and compliance with severance and release agreement.
No successor appointed; CEO James Mullen signed the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Lisa Michaels

Chief Medical Officer

EDIT · Editas Medicine, Inc.

Effective: 2022-02-07
Filed: February 7, 2022, 6:59 PM ET

On February 7, 2022, Lisa Michaels’ employment with Editas Medicine, Inc. (the “Company”) as Chief Medical Officer was terminated, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lisa Michaels was terminated as Chief Medical Officer at Editas Medicine, Inc..

Action: terminated
Role: Chief Medical Officer

Exact text from the filing

On February 7, 2022, Lisa Michaels’ employment with Editas Medicine, Inc. (the “Company”) as Chief Medical Officer was terminated, effective immediately.

View on SEC.gov

Editas Medicine, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-22-000862

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.